118ͼ¿â

Charlotte Bevan is Professor of Biology and leads the prostate cancer research group at the  Department of Surgery and Cancer, Imperial College London.  Her research has focussed on prostate cancer for over 20 years, beginning during her postdoctoral fellowship at the ICRF Lincoln’s Inn Fields Laboratories before moving to Imperial College in 1999. A major focus of Charlotte Bevan’s research is mechanisms of androgen signalling and its role in development and disease. This began during her PhD at the University of Cambridge which was concerned with androgen insensitivity syndrome, a paediatric condition. Since androgen signalling is key in prostate cancer progression and therapy, prostate cancer is her group’s major focus. However their research interests have expanded to include the study of key non-coding RNAs in prostate (and other) cancers, the role of the microenvironment in disease progression, the abscopal effect, as well as mechanisms of escape from hormonal control of prostate tumours. Importantly, she has a number of collaborations with the physcial sciences to pursue convergence science approaches to drug delivery and biomarker detection. 
 
In addition to her research, Prof Bevan has several teaching roles, acts as a mentor for early career researchers, and is the Director of Postgraduate Studies for her Dept, overseeing the progress of all PhD students. She has also been a longstanding member of the Research  Advisory Committees of Prostate Cancer UK and Tenovus Cancer Care, and member of many national and international review panels and conference organising committees. She was previously a member of the 118ͼ¿â Executive Committee and is committed to supporting and promoting u and coming cancer research scientists in all these roles. 
 

« Back